VERICEL CORP (VCEL)
US92346J1088 - Common Stock
We assign a fundamental rating of 5 out of 10 to VCEL. VCEL was compared to 587 industry peers in the Biotechnology industry. VCEL has an excellent financial health rating, but there are some minor concerns on its profitability. VCEL is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
In the past year VCEL has reported negative net income.
In the past year VCEL had a positive cash flow from operations.
VCEL had negative earnings in 4 of the past 5 years.
VCEL had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 0.13%, VCEL belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
The Return On Equity of VCEL (0.19%) is better than 93.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.13% | ||
| ROE | 0.19% | ||
| ROIC | N/A |
ROA(3y)-3.36%
ROA(5y)-3%
ROE(3y)-4.83%
ROE(5y)-4.21%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 0.22%, VCEL belongs to the top of the industry, outperforming 93.68% of the companies in the same industry.
Looking at the Gross Margin, with a value of 69.50%, VCEL belongs to the top of the industry, outperforming 84.10% of the companies in the same industry.
In the last couple of years the Gross Margin of VCEL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 0.22% | ||
| GM | 69.5% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.41%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
VCEL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, VCEL has more shares outstanding
The number of shares outstanding for VCEL has been increased compared to 5 years ago.
VCEL has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 11.15 indicates that VCEL is not in any danger for bankruptcy at the moment.
VCEL has a better Altman-Z score (11.15) than 87.18% of its industry peers.
The Debt to FCF ratio of VCEL is 0.08, which is an excellent value as it means it would take VCEL, only 0.08 years of fcf income to pay off all of its debts.
VCEL has a Debt to FCF ratio of 0.08. This is amongst the best in the industry. VCEL outperforms 97.78% of its industry peers.
VCEL has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, VCEL is in line with its industry, outperforming 50.26% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.08 | ||
| Altman-Z | 11.15 |
ROIC/WACCN/A
WACC9.1%
2.3 Liquidity
A Current Ratio of 5.20 indicates that VCEL has no problem at all paying its short term obligations.
VCEL has a Current ratio (5.20) which is in line with its industry peers.
A Quick Ratio of 4.83 indicates that VCEL has no problem at all paying its short term obligations.
VCEL has a Quick ratio (4.83) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.2 | ||
| Quick Ratio | 4.83 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 97.30% over the past year.
VCEL shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.72%.
Measured over the past years, VCEL shows a quite strong growth in Revenue. The Revenue has been growing by 16.79% on average per year.
EPS 1Y (TTM)97.3%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q50%
Revenue 1Y (TTM)22.72%
Revenue growth 3Y16.72%
Revenue growth 5Y16.79%
Revenue growth Q2Q25.01%
3.2 Future
VCEL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 81.68% yearly.
The Revenue is expected to grow by 24.57% on average over the next years. This is a very strong growth
EPS Next Y190.86%
EPS Next 2Y174.32%
EPS Next 3Y127.08%
EPS Next 5Y81.68%
Revenue Next Year21.77%
Revenue Next 2Y23.4%
Revenue Next 3Y24.14%
Revenue Next 5Y24.57%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for VCEL. In the last year negative earnings were reported.
VCEL is valuated quite expensively with a Price/Forward Earnings ratio of 99.37.
92.65% of the companies in the same industry are more expensive than VCEL, based on the Price/Forward Earnings ratio.
VCEL's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 20.51.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 99.37 |
4.2 Price Multiples
VCEL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. VCEL is cheaper than 93.50% of the companies in the same industry.
94.19% of the companies in the same industry are more expensive than VCEL, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1175.83 | ||
| EV/EBITDA | 2034.87 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
VCEL's earnings are expected to grow with 127.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y174.32%
EPS Next 3Y127.08%
5. Dividend
5.1 Amount
VCEL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
VERICEL CORP
NASDAQ:VCEL (5/15/2024, 7:15:03 PM)
After market: 49.41 0 (0%)49.41
+0.88 (+1.81%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.39B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 99.37 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.13% | ||
| ROE | 0.19% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | 0.22% | ||
| GM | 69.5% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 5.2 | ||
| Quick Ratio | 4.83 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)97.3%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y190.86%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)22.72%
Revenue growth 3Y16.72%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y